Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.675 CHF | -3.03% | +4.40% | +6.83% |
Mar. 15 | Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024 | |
Mar. 15 | Molecular Partners Swings to Loss in FY23; Revenue Down | MT |
Business Summary
Number of employees: 168
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 190 | 100.0 % | 7 | 100.0 % | -96.29% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 180 | 94.9 % | 7 | 100.0 % | -96.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 52 | 04-11-22 | |
Patrick Amstutz
FOU | Founder | 49 | 04-11-22 |
Michael Pitzner
CMP | Compliance Officer | - | 22-10-31 |
Chief Operating Officer | - | 22-06-30 | |
Philippe Legenne
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Daniel Steiner
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
Baris Arican
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Seth D. Lewis
IRC | Investor Relations Contact | - | 19-10-31 |
Renate Gloggner
HRO | Human Resources Officer | - | 21-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Burns
CHM | Chairman | 76 | 17-10-30 |
Steven Holtzman
BRD | Director/Board Member | 70 | 14-09-18 |
Vito Palombella
BRD | Director/Board Member | 61 | 20-03-31 |
Patrick Amstutz
FOU | Founder | 49 | 04-11-22 |
Director/Board Member | 47 | 21-04-20 | |
Director/Board Member | 61 | 20-04-28 | |
Director/Board Member | 53 | 20-03-31 | |
Dominik Höchli
BRD | Director/Board Member | 57 | 21-04-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,368,901 | 29,497,085 ( 81.11 %) | 3,500,000 ( 9.624 %) | 81.11 % |
Company contact information
Sector
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.83% | 134M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Molecular Partners AG - Swiss Exchange
- Company Molecular Partners AG